Результаты поиска

Peritoneal Amyloid as a Presenting Manifestation of AL Amyloid.

Amyloid is a systemic disease characterized by extracellular deposition of misfolded protein. Gastrointestinal and peritoneal deposition of light chain (AL) amyloid is an under-recognized manifestation of this systemic disease, usually as a late sequela. Here we present a case of recently diagnosed AL peritoneal amyloid that presented in the context of recurrent, acute onset abdominal discomfort and was found to have bowel obstruction complicated by perforation in the setting of AL-mediated gastrointestinal tract infiltration and dysmotility.

Plasma Erythropoietin Levels and Anemia in Vietnamese Patients With Type 2 Diabetes and Chronic Kidney Disease: 2018-2019.

Background and aimEndogenous erythropoietin (EPO) deficiency has been associated with anemia in patients with type 2 diabetes mellitus (T2DM) and renal injury. The purpose of this study was to characterize EPO levels and anemia in Vietnamese patients with T2DM and chronic kidney disease (CKD).MethodsA prospective observational study was conducted with 219 patients who were selected: 129 with T2DM and CKD, 51 with T2DM without CKD, and 49 healthy controls. Kruskal-Wallis, Chi-square tests, and univariate ROC curve analysis were conducted to evaluate the predictive value of variables for anemia

Prognostic value of low muscle mass at the 12th thoracic vertebral level in multiple myeloma treated with transplantation: CAREMM-2101 study.

PurposeAutologous hematopoietic stem cell transplantation (ASCT) has been introduced as a standard treatment for newly diagnosed multiple myeloma (NDMM) following novel agent-based induction chemotherapy. This study investigated whether pre-ASCT low muscle mass evaluated using the paraspinal muscle index (PMI) at the 12th thoracic vertebra (T12) level is a reliable prognostic marker in NDMM after chemotherapy.MethodsA multi-center registry database was retrospectively analyzed. Between 2009 and 2020, 190 patients with chest computed tomography images underwent frontline ASCT following inductio

Esid 2014 oral presentations.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Корреляция когнитивных дисфункций и мер по диффузионному измерению МРТ в предметах, имеющих ОРД.

КОЛИЧЕСТВО: Когнитивная дисфункция - это обычное нарушение, наблюдаемое у лиц с множественным склерозом (MS), затрагивающее такие ключевые области, как внимание, скорость обработки информации, память и исполнительные функции. Этот дефицит, как правило, выявляется на основе всеобъемлющих нейропсихологических оценок, которые представляют собой золотой стандарт для когнитивной оценки. В последние годы были активизированы усилия по интеграции нейропсихологических результатов с передовыми методами нейроимации, с тем чтобы лучше понять нейронные субстраты когнитивной дисфункции. Среди них Difsusion

Drug-Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC-122) in Healthy Adult Subjects.

Avadomide (CC-122) is a novel immunomodulatory drug that binds to cereblon, a member of the Cullin 4-RING E3 ubiquitin ligase complex. Avadomide has multiple pharmacologic activities including potent immune modulation, antiangiogenic, antitumor, and antiproliferative activity and is being evaluated as an oncology treatment for hematologic malignancies and advanced solid tumors. In vitro study has indicated that cytochrome P450 (CYP) 3A and CYP1A2 appear to be the major enzymes involved in the oxidative metabolism of avadomide. The effects of CYP3A inhibition/induction and CYP1A2 inhibition on

Antineoplastic effects of CPPTL via the ROS/JNK pathway in acute myeloid leukemia.

Drug resistance and human leukocyte antigen (HLA) matching limit conventional treatment of acute myeloid leukemia (AML). Although several small molecule drugs are clinically used, single drug administration is not sufficient to cure AML, which has a high molecular diversity. Metabolic homeostasis plays a key role in determining cellular fate. Appropriate levels of reactive oxygen species (ROS) maintain the redox system balance, and excessive amounts of ROS cause oxidative damage, thus providing a strategy to eliminate cancer cells. CPPTL is a novel analogue of parthenolide that exhibited signi

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.

Ankaferd blood stopper is a standardized mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica and has been used as a topical hemostatic agent and with its clinical application established in randomized controlled trials and case reports. Ankaferd has been successfully used in gastrointestinal endobronchial mucosal and cutaneous bleedings and also in abdominal, thoracic, dental and oropharyngeal, and pelvic surgeries. Ankaferd's hemostatic action is thought to form a protein complex with coagulation factors that facilitate adhesion of

Совпадение в полном тексте источника
… ACB: autogenous cortical bone greft, ABS: Ankaferd blood stopper; AOT: Oral anticoagulant therapy; CABG: coronary artery bypass grafting; ASA: acetylsalicylic acid; INR: international normalized ratio; GIS: gastrointestinal system; GR: gingival recession; HCT : hemostasis by conventional technique; PCNL … J Endourol 2013 ; 27 : 1126 – 1130 . 23731234 10.1089/end.2013.0086 22 Amer MZ Mourad SI Salem AS Correlation between international normalized ratio values and sufficiency of two different local hemostatic measures in anticoagulated patients . …

A cervical spine metastasis of a hepatocellular carcinoma: a rare presentation.

BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality globally, with bone metastases signifying advanced disease and a poor prognosis. Although bone metastases in HCC are relatively uncommon, they present significant diagnostic and therapeutic challenges. We present a rare case of cervical spine metastasis as a presenting feature of HCC progression, highlighting the need for timely diagnosis and multidisciplinary care. CASE PRESENTATION: A 55-year-old North African female with a history of hepatitis C-related cirrhosis, successfully treated with antiviral t

Совпадение в полном тексте источника
… The prothrombin time (PT) was within normal limits at 76%, with an international normalized ratio (INR) of 1.1. Liver enzyme levels were within normal limits. Alpha-fetoprotein level (AFP) was 124 IU/l(4-fold the upper limit of normal (ULN). The CA19-9 level was normal. …

Доклад о серьезном миелин олигодендроците гликпротеина, связанном с антителными заболеваниями, после эктической беременности и лапароскопического медицинского аборта: значение периферического воспаления для демиелинизирующей деятельности.

Myelin oligendrocyte glycoprotein - болезнь, связанная с антителами (MOGAD) - редкое неврологическое заболевание. Одной из важных причин материнской заболеваемости и смертности во всем мире является внематочная беременность в Тубале. Регулярная беременность оказывает воздействие на MOGAD, приводя к увеличению числа рецидивов в послеродовой период. Тем не менее не существует ни сообщений о конкретных случаях, ни когортных исследований, посвященных абортам и эктуальной беременности в качестве события, способствующего изменению болезней в рамках МУГАД. Это отчет о серьезном рецидиве MOGAD после э

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?

Multiple myeloma (MM) is characterized by recurrent relapses. Consequently, patients receive multiple therapy lines, including alkylating agents and immune modulators, which have been associated with secondary malignancies such as myelodysplastic syndrome (MDS). Anti-B-cell maturation antigen (BCMA) chimeric antigen receptor T cell (CART) therapy is efficacious in patients with relapsed/refractory (R/R) MM. However, the long-term complications, particularly MDS, are not well understood. Whether CART therapy causes or promotes MDS has not been thoroughly investigated. In this study, we explored

Antibodies to watch in 2023.

In this 14th installment of the annual Antibodies to Watch article series, we discuss key events in commercial monoclonal antibody therapeutics development that occurred in 2022 and forecast events that might occur in 2023. As of mid-November, 12 antibody therapeutics had been granted first approvals in either the United States or European Union (tebentafusp (Kimmtrak), faricimab (Vabysmo), sutimlimab (Enjaymo), relatlimab (Opdualag), tixagevimab/cilgavimab (Evusheld), mosunetuzumab (Lunsumio), teclistamab (TECVAYLI), spesolimab (SPEVIGO), tremelimumab (Imjudo; combo with durvalumab), nirsevim

Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis.

ObjectivesCirc_003686 is a novel_circRNA with abnormally low expression found in the samples of multiple myeloma bone disease (MBD) patients. The current research intended to investigate the effects of novel_circ_003686 in osteogenesis-induced differentiation of bone marrow mesenchymal stem cells (BMSCs) in MBD.MethodsBMSCs were extracted from MBD patients and normal participants, the pcDNA3.1 encoding the circ_003686 (ov-circ_003686), miR-142-5p-mimic/inhibitor and siRNA oligonucleotides targeting insulin like growth factor 1 (IGF1, si-IGF1) were applied to intervene circ_003686, miR-142-5p a

Сопоставительная оценка иммуногенности биоаналоговой и эталонной медицины: соответствующая характеристика иммуногенности.

КОЛИЧЕСТВО: Биоаналогичная натализумаб (биосим-НТЗ) является первой биоаналогичной моноклонной антителой, используемой для лечения повторных форм множественных склерозов (MS). В рамках всей совокупности доказательств для демонстрации биоаналогичности оценки иммуногенности проводились на здоровых предметах и пациентах с повторно излучающими эмиссию MS (RRMS) в целях подтверждения соответствия иммуногенности между биосим-NTZ и ref-NTZ. МЕТОДЫ: Иммуногенность биосим-НТЗ в сравнении с реф-НТЗ оценивалась в рамках двух важнейших клинических исследований. В ходе сравнительного исследования эффективн

Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study.

BackgroundDaratumumab (Dara) is generally well tolerated, but is associated with increased risk of infection.MethodsWe investigated hypogammaglobinemia occurrence in different Dara-based regimens. Multiple myeloma (MM) patients were treated with ⩾2 cycles of Dara-based therapy during 2016-2020, mainly for relapsed/refractory disease. Data on patient characteristics, treatment regimens, polyclonal IgG (poly-IgG) and uninvolved free light chain (Un-FLC) levels during treatment, as well as predictors for hypogammaglobinemia and predictors for infections, were evaluated retrospectively.ResultsA to

Oral foci of infection and their relationship with hospital stay after haematopoietic cell transplantation.

PurposeOral focus screening is recommended before HCT (haematopoietic cell transplantation). Acute foci are generally treated pre-HCT. However, it is unclear whether chronic foci should be treated pre-HCT. This study aimed to evaluate the association between number of foci and early post-HCT morbidity and mortality.MethodsPatients who received an oral screening pre-HCT at Radboudumc between 2013 and 2023, with a recent panoramic radiograph, were included. Foci were defined as teeth or implants with deep pockets, furcation radiolucencies, periapical radiolucencies, deep caries, partial eruption

Иммуномодуляторы и иммунопрессанты для прогрессивного множественного склероза: сетевой метаанализ.

В последние годы для лиц с прогрессивными формами множественного склероза (ПМС) был разработан более широкий спектр методов иммуномодуляционного и иммуноподавляющего лечения. Хотя консенсус поддерживает эти варианты в качестве сокращения рецидивов, их относительные преимущества и характеристики безопасности остаются неясными из-за отсутствия прямых сравнительных испытаний. 1-a и бета 1-bИнтерферон beta-1b (Бетаферон), интерферон beta-1a (Avonex, Rebif), лакинимод, лефлюномид, метотрексат, миноциклин, митоксантрон, микофенолат мофетил, натализумаб, окролизумаб, атумумаб, озанимод, пегилированны

Fracture severity dependence of bone and muscle performance in patients following single or multiple vertebral fractures.

BACKGROUND: Few studies focus on the clinical, laboratory, radiological, and biological characteristics of bone and muscle of multiple vertebral fractures, which are associated with a more poor prognosis compared with single fracture. PURPOSE: To compare the BMD, bone turnover, muscularity, fatty infiltration of muscle, and prevalence of co-morbidities in patients with single and multiple vertebral fractures. METHODS: We recruited 100 patients with single fracture (age 66.96 ± 8.24 years) and 100 with multiple fractures (age 69.90 ± 7.80 years); performed dual-energy X-ray absorptiometry of

Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events.

BackgroundEpoetin-beta is used to treat patients with cancer undergoing chemotherapy to alleviate the symptoms of anaemia, reduce the risk of blood transfusions and improve quality of life (QoL).MethodsThis meta-analysis of all 12 randomised, controlled studies of epoetin-beta evaluated the impact of therapy at different Hb-initiation levels and to different target Hb levels on overall survival, tumour progression and thromboembolic events (TEE). An analysis of risk factors pre-disposing patients to TEEs under epoetin-beta therapy was also performed. A total of 2297 patients are included in th

Therapeutic Approach in the Treatment of Medication-Related Osteonecrosis of the Jaw: Case Series of 3 Patients and State of the Art on Surgical Strategies.

BACKGROUND: Bisphosphonates and receptor activator of nuclear factor kappa-B ligand inhibitors are currently the most widely used antiresorptive therapies in bone metabolism diseases treatment. Unfortunately they can evoke medication-related osteonecrosis of the jaws. The present case series study proposes to evaluate clinical features, evolution and the surgical therapeutic approaches in three patients affected by medication-related osteonecrosis of the jaw and to review the state of art regarding the management of this complication in light of the most recent literature. METHODS: Three case